Dr. Manel Esteller and Dr. Verónica Dávalos, researchers at the Josep Carreras Leukaemia Research Institute, describe in a new article the impact of epigenetics on cancer treatment and how it has become a crucial tool to improve early detection, predict disease progression and become a target for new treatments.
source https://www.pharmatutor.org/pharma-news/2022/epigenetics-breaks-into-the-clinical-practice-of-cancer
No comments:
Post a Comment